These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 10634392)

  • 1. Antifracture efficacy of antiresorptive agents are related to changes in bone density.
    Wasnich RD; Miller PD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):231-6. PubMed ID: 10634392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents.
    Hochberg MC; Greenspan S; Wasnich RD; Miller P; Thompson DE; Ross PD
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1586-92. PubMed ID: 11932287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between changes in bone mineral density and fracture risk reduction with antiresorptive drugs: some issues with meta-analyses.
    Delmas PD; Li Z; Cooper C
    J Bone Miner Res; 2004 Feb; 19(2):330-7. PubMed ID: 14969404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD.
    Watts NB; Geusens P; Barton IP; Felsenberg D
    J Bone Miner Res; 2005 Dec; 20(12):2097-104. PubMed ID: 16294263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ; Naganathan V; Barton I; Grauer A
    J Bone Miner Res; 2004 Feb; 19(2):323-9. PubMed ID: 14969403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis.
    Vestergaard P; Jorgensen NR; Mosekilde L; Schwarz P
    Osteoporos Int; 2007 Jan; 18(1):45-57. PubMed ID: 16951908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increase in bone mineral density and its effect on fracture risk].
    Sone T
    Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
    Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
    J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug therapy for vertebral fractures in osteoporosis: evidence that decreases in bone turnover and increases in bone mass both determine antifracture efficacy.
    Riggs BL; Melton LJ; O'Fallon WM
    Bone; 1996 Mar; 18(3 Suppl):197S-201S. PubMed ID: 8777088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
    Eastell R; Barton I; Hannon RA; Chines A; Garnero P; Delmas PD
    J Bone Miner Res; 2003 Jun; 18(6):1051-6. PubMed ID: 12817758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint.
    Marcus R; Wong M; Heath H; Stock JL
    Endocr Rev; 2002 Feb; 23(1):16-37. PubMed ID: 11844743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duration of antiresorptive effects of low-dose zoledronate in osteopenic postmenopausal women: a randomized, placebo-controlled trial.
    Grey A; Bolland M; Mihov B; Wong S; Horne A; Gamble G; Reid IR
    J Bone Miner Res; 2014 Jan; 29(1):166-72. PubMed ID: 23761303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive review of treatments for postmenopausal osteoporosis.
    Häuselmann HJ; Rizzoli R
    Osteoporos Int; 2003 Jan; 14(1):2-12. PubMed ID: 12577179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of teriparatide on bone mineral density and fracture in postmenopausal osteoporosis: meta-analysis of randomised controlled trials.
    Han SL; Wan SL
    Int J Clin Pract; 2012 Feb; 66(2):199-209. PubMed ID: 22257045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy.
    Delmas PD; Seeman E
    Bone; 2004 Apr; 34(4):599-604. PubMed ID: 15050889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis.
    Richy F; Schacht E; Bruyere O; Ethgen O; Gourlay M; Reginster JY
    Calcif Tissue Int; 2005 Mar; 76(3):176-86. PubMed ID: 15692726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.
    Lindsay R; Nieves J; Formica C; Henneman E; Woelfert L; Shen V; Dempster D; Cosman F
    Lancet; 1997 Aug; 350(9077):550-5. PubMed ID: 9284777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with alendronate prevents fractures in women at highest risk: results from the Fracture Intervention Trial.
    Ensrud KE; Black DM; Palermo L; Bauer DC; Barrett-Connor E; Quandt SA; Thompson DE; Karpf DB
    Arch Intern Med; 1997 Dec 8-22; 157(22):2617-24. PubMed ID: 9531231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring osteoporosis therapy: bone mineral density, bone turnover markers, or both?
    Bonnick SL; Shulman L
    Am J Med; 2006 Apr; 119(4 Suppl 1):S25-31. PubMed ID: 16563938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.